Impact of dose reductions of platinum compounds on survival in stage IIIB/IV non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Yumuk, P. F. [1 ]
Teomete, M. [1 ]
Dane, F. [1 ]
Cabuk, D. [1 ]
Basaran, G. [1 ]
Turhal, N. S. [1 ]
机构：
[1] Marmara Univ, Med Sch Hosp, Istanbul, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19055
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Prognostic impact of prognostic nutritional index in advanced (stage IIIB/IV) non-small cell lung cancer patients
    Li, X. L.
    Yao, Z. H.
    Wan, Y. Y.
    Mou, X. Y.
    Ni, Y. H.
    Sun, E. L.
    Zang, D.
    Lin, D. J.
    NEOPLASMA, 2019, 66 (06) : 971 - 977
  • [32] Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC):: a multicentre phase II clinical trial
    Palmeri, S
    Leonardi, V
    Gebbia, V
    De Bella, MT
    Ferraù, F
    Faillù, G
    Spatafora, M
    Valenza, R
    Di Vita, G
    Vitello, S
    Carroccio, R
    Sciortino, G
    Vaglica, M
    Accurso, V
    Agostara, B
    Licata, G
    LUNG CANCER, 2001, 34 (01) : 115 - 123
  • [33] A prospective audit on toxicity and clinical outcomes for platinum-based chemotherapy in stage IIIB/IV non-small cell lung cancer (NSCLC): a West of Scotland analysis
    Ali, C.
    Kumari, M.
    Mcphelim, J.
    Maclean, F.
    Cadwallader, S.
    Hicks, J.
    LUNG CANCER, 2016, 91 : S27 - S27
  • [34] Impact of New Chemotherapeutic and Targeted Agents on Survival in Stage IV Non-Small Cell Lung Cancer
    Yu, Joanne L.
    Simmons, Christine
    Victor, J. Charles
    Han, Dolly
    Hogeveen, Sophie
    Leighl, Natasha
    Verma, Sunil
    ONCOLOGIST, 2011, 16 (09): : 1307 - 1315
  • [35] Impact of new chemotherapeutic and targeted agents on survival in stage IV non-small cell lung cancer
    Yu, J. L.
    Simmons, C. E.
    Victor, C.
    Han, D.
    Hogeveen, S.
    Leighl, N. B.
    Verma, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [36] Trends in immunotherapy use and survival impact in stage IV non-small cell lung cancer.
    Otaibi, Zachary
    Kamran, Amir
    Wegner, Rodney E.
    Colonias, Athanasios
    Weksler, Benny
    Finley, Gene Grant
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] Guidelines on treatment of stage IIIB non-small cell lung cancer
    Jett, JR
    Scott, WJ
    Rivera, MP
    Sause, WT
    CHEST, 2003, 123 (01) : 221S - 225S
  • [38] Treatment Patterns and Survival of Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC) in the Era of Novel Therapies
    Yusuf, D.
    Hurry, M.
    Walton, R.
    Cheung, W.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S1002 - S1002
  • [39] Three-year survival in stage IV non-small cell lung cancer (NSCLC): The importance of metastatic distribution
    Karp, Daniel D.
    Hanneken, Jan M.
    Taylor, Sarah H.
    Men, Taoyan
    Wu, Xifeng
    Pu, Xia
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [40] Real World Treatment Patterns and Survival of Stage IV Non-Small Cell Lung Cancer (NSCLC) in Ontario, Canada
    Seung, S. J.
    Hurry, M.
    Walton, R.
    Evans, W.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S624 - S624
12345